BMY.RT
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
BMY.RT
Delisted
BMY.RT was delisted on the 31st of December, 2020.
12 hedge funds and large institutions have $5.25M invested in Bristol-Myers Squibb Company Contingent Value Rights in 2021 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 527 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
100% less funds holding in top 10
Funds holding in top 10: 5 → 0 (-5)
Holders
12
Holding in Top 10
–
Calls
–
Puts
–
Top Sellers
| 1 | -$47.7M | |
| 2 | -$20.6M | |
| 3 | -$17.1M | |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$14.8M |
| 5 |
BFS
Bard Financial Services
Branford,
Connecticut
|
-$13.7M |